Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Charles River Laboratories (CRL)

Charles River Labs shareholders elect 12 directors, approve 2026 incentive plan

Neutral Impact 2 of 5 shareholder Written later

At its May 5, 2026 annual meeting, Charles River Laboratories shareholders elected all 12 director nominees, approved a new 2026 Long-Term Incentive Plan, approved executive pay on an advisory basis, and ratified PricewaterhouseCoopers LLP as auditor for fiscal 2026. The votes are routine annual-meeting matters with no change in financial results or guidance reported in this filing.

Key points

  • All 12 directors were elected to serve until the 2027 annual meeting; each received more votes for than against.
  • The 2026 Long-Term Incentive Plan was approved with 41,523,179 votes for and 2,561,994 against.
  • Advisory say-on-pay was approved with 41,356,139 votes for and 2,716,251 against.
  • PricewaterhouseCoopers LLP was ratified as independent auditor for fiscal 2026 with 43,646,371 votes for.

The filing

CompanyCharles River Laboratories (CRL)
Form8-K, current report
Filed with the SECMay 11, 2026, 5:01 PM ET
Accession number0000950103-26-007060

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.